Personalized cell cycle synchronization as adjuvant therapeutic approach for glioma: hitting the tumor hard
Bijdrage Stichting STOPhersentumoren.nl: 101.150,- euro per 1 november 2014
Deciphering intratumoral heterogeneity in glioblastoma by transitioning from singleplex to multiplex anti-glioma drug response monitoring
Bijdrage Stichting STOPhersentumoren.nl: 50.000,- euro per 1 november 2014
Development of strategies to enhance viro-immunotherapy of glioblastoma
Bijdrage Stichting STOPhersentumoren.nl: 130.000,- euro per 1 november 2014
Therapy Selection in 3D Glioma Models using Novel Organ-on-a-Chip Technology
Bijdrage Stichting STOPhersentumoren.nl: 135.900,- euro per 1 november 2014
Gliomen met genetische kenmerken van pilocytaire astrocytomen
Bijdrage Stichting STOPhersentumoren.nl: 14.920,- euro per 1 november 2014
